GLAXOSMITHKLINE PLC's ticker is GSK and the CUSIP is 37733W105. A total of 8 filers reported holding GLAXOSMITHKLINE PLC in Q3 2023. The put-call ratio across all filers is - and the average weighting 0.9%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2017 | $244,000 | -5.8% | 5,998 | 0.0% | 0.01% | -11.1% |
| Q2 2017 | $259,000 | +2.4% | 5,998 | 0.0% | 0.01% | 0.0% |
| Q1 2017 | $253,000 | +9.5% | 5,998 | 0.0% | 0.01% | +12.5% |
| Q4 2016 | $231,000 | -20.9% | 5,998 | -11.4% | 0.01% | -27.3% |
| Q3 2016 | $292,000 | -0.7% | 6,773 | 0.0% | 0.01% | +10.0% |
| Q2 2016 | $294,000 | +6.9% | 6,773 | 0.0% | 0.01% | 0.0% |
| Q1 2016 | $275,000 | -43.5% | 6,773 | -43.9% | 0.01% | -41.2% |
| Q4 2015 | $487,000 | -5.4% | 12,073 | -9.8% | 0.02% | +6.2% |
| Q3 2015 | $515,000 | -29.6% | 13,390 | -23.8% | 0.02% | -15.8% |
| Q2 2015 | $732,000 | -9.7% | 17,577 | 0.0% | 0.02% | -5.0% |
| Q1 2015 | $811,000 | +8.0% | 17,577 | 0.0% | 0.02% | +11.1% |
| Q4 2014 | $751,000 | -6.9% | 17,577 | +0.1% | 0.02% | -5.3% |
| Q3 2014 | $807,000 | -14.1% | 17,560 | 0.0% | 0.02% | -9.5% |
| Q2 2014 | $939,000 | +0.1% | 17,560 | 0.0% | 0.02% | -4.5% |
| Q1 2014 | $938,000 | -1.7% | 17,560 | -1.7% | 0.02% | -4.3% |
| Q4 2013 | $954,000 | -4.7% | 17,870 | -10.5% | 0.02% | -11.5% |
| Q3 2013 | $1,001,000 | -0.5% | 19,960 | -0.9% | 0.03% | -3.7% |
| Q2 2013 | $1,006,000 | – | 20,142 | – | 0.03% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Sio Capital Management, LLC | 325,823 | $11,557,000 | 6.52% |
| KAHN BROTHERS GROUP INC | 1,139,163 | $40,406,111,000 | 6.35% |
| Chubb Ltd | 400,000 | $14,188,000 | 6.18% |
| Healthcare Value Capital, LLC | 50,000 | $1,774,000 | 5.40% |
| CLARK ESTATES INC/NY | 650,000 | $23,056,000 | 3.81% |
| PVG ASSET MANAGEMENT CORP | 220,450 | $7,819,361,000 | 3.57% |
| Martin Capital Partners, LLC | 88,195 | $3,128,000 | 3.25% |
| Camber Capital Management LP | 1,500,000 | $53,205,000 | 2.60% |
| EQUITY INVESTMENT CORP | 2,090,120 | $74,137,000 | 2.47% |
| Keystone Financial Planning, Inc. | 129,102 | $4,579,000 | 2.44% |